Home
Conditions
Myeloproliferative Disorders

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

506 public trials 83 recruiting studies

Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Recruiting

Ivosidenib and Ruxolitinib in Patients With Advanced Myeloproliferative Neoplasms (MPNs) That Have an IDH1 Gene Mutation

NCT06291987

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: University of Chicago Medicine Comprehensive Cancer Center Chicago, Illinois, United States

Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

NCT06661915

Conditions: Accelerated Phase Myeloproliferative Neoplasm, Blast Phase Myeloproliferative Neoplasm, Blood Coagulation Disorders, +19 more
Locations: UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

Stanford Cancer Institute Palo Alto Palo Alto, California, United States

University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View all 31 locations

View Trial Details

Recruiting

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

NCT06523556

Conditions: Atypical Chronic Myeloid Leukemia, Bone Marrow Diseases, Chronic Disease, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Project: Every Child for Younger Patients With Cancer

NCT02402244

Conditions: Adrenal Gland Pheochromocytoma, Bone Marrow Diseases, Carcinoma, +59 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

USA Health Strada Patient Care Center Mobile, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Kingman Regional Medical Center Kingman, Arizona, United States

View all 279 locations

View Trial Details

Recruiting

CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT04493164

Conditions: Acute Myeloid Leukemia With Gene Mutations, Bone Marrow Diseases, Hematologic Diseases, +12 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

NCT04898790

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +20 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Recruiting

Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies

NCT07565220

Conditions: Acute Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), +19 more
Locations: UMPC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes

NCT06361641

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +14 more
Locations: GOUBAND Agathe Angers, Maine et Loire, France

BESCOND Charles Cholet, Maine et Loire, France

TRUCHAN-GRACZYK Malgorzata Saumur, Maine et Loire, France

View Trial Details

Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

NCT07008118

Conditions: Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +8 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

Stanford University Palo Alto, California, United States

Colorado Blood Cancer Institute Denver, Colorado, United States

Mayo Clinic-Florida Jacksonville, Florida, United States

View all 26 locations

View Trial Details

Recruiting

Ropeginterferon for High Risk JAK2 Clonal Hematopoiesis

NCT07249840

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Mass General Brigham Boston, Massachusetts, United States

View Trial Details

Myeloproliferative Disorders

Myeloproliferative Disorders trial results

Related conditions